Transitional Case Management Study
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00264329|
Recruitment Status : Completed
First Posted : December 12, 2005
Last Update Posted : November 18, 2016
|Condition or disease||Intervention/treatment||Phase|
|Substance-Related Disorders||Other: Transitional Case Management Study||Phase 3|
To address the issues involved in treatment participation by substance-abusing parolees, the CJ-DATS Transitional Case Management (TCM) study proposes to test a parole re-entry model that consists of (1) completion by the inmate of a strengths and goals assessment as part of discharge planning, (2) a telephone case conference call that includes the inmate and significant members of the inmate's aftercare plan (including the parole officer), and (3) strengths case management (for 12 weeks) in the community to promote treatment participation and support the client's access to needed services.
More specifically, the multi-site study will evaluate the effects of a strengths case-management intervention on community-based treatment/service admission, retention, and utilization among inmates released from supervised treatment programs. If the intervention is successful, its wider adoption would increase the likelihood that inmates enter and remain in community services.
The specific aims of this multi-site study are to:
- Increase the likelihood that offenders leaving prison (or other supervised setting) with a referral to community aftercare program services enroll in treatment.
- Increase the amount of time that such offenders participate in community treatment.
- Assist clients to get the services that they need during the first 12 weeks of return to the community.
- As a result of the above, reduce relapse and reoffending during and following treatment.
- Achieve the above results at a favorable cost-effectiveness ratio.
- Encourage closer collaboration between the treatment and criminal justice systems.
Study participants (200 at each site, 25% of will be women) will be recruited in prison (or other confined setting) from inmates who have a referral to community treatment. After informed consent and a baseline interview, they will be randomly assigned to one of two conditions: (1) the Transitional Case Management condition, and (2) the Standard Referral condition (i.e., usual transition/re-entry procedures used by the facility, including a referral to community treatment).
Individual-level outcomes will include (1) treatment admission and participation (based on data collected from programs), (2) drug use, criminal activity, and psychosocial functioning (based on telephone interviews conducted 3 months after the end of the intervention) and (3) recidivism (based on records collected 12 months after the end of the intervention). The study will also assess the impact of the intervention on organizational and system factors (based on information from the case manager, treatment staff, and criminal justice staff) and the cost effectiveness of the intervention.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||812 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Transitional Case Management Study|
|Study Start Date :||November 2004|
|Actual Primary Completion Date :||April 2006|
|Actual Study Completion Date :||May 2008|
Other: Transitional Case Management Study
- Treatment admission by three months following parole [ Time Frame: Three months ]
- Treatment retention by three months following parole [ Time Frame: Three months ]
- Drug use at nine months following parole [ Time Frame: Nine months ]
- Recidivism at nine months following parole [ Time Frame: Nine months ]
- Education and employment at nine months following parole [ Time Frame: Nine months ]
- HIV risk behaviors at nine months following parole [ Time Frame: Nine months ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00264329
|United States, California|
|University of California, Los Angeles|
|Los Angeles, California, United States, 90025|
|United States, Connecticut|
|Connecticut Department of Mental Health and Addiction Services|
|Hartford, Connecticut, United States, 06134|
|United States, Kentucky|
|University of Kentucky|
|Lexington, Kentucky, United States, 40506|
|United States, New York|
|National Development and Research Institutes, Inc. (NDRI)|
|New York, New York, United States, 10048|
|Principal Investigator:||Michael L Prendergast, Ph.D.||University of California, Los Angeles|
|Study Director:||Jerome Cartier, M.S.||University of California, Los Angeles|